Matches in Wikidata for { <http://www.wikidata.org/entity/Q37369917> ?p ?o ?g. }
- Q37369917 description "article científic" @default.
- Q37369917 description "article scientifique" @default.
- Q37369917 description "articolo scientifico" @default.
- Q37369917 description "artigo científico" @default.
- Q37369917 description "artículu científicu espublizáu en 2009" @default.
- Q37369917 description "bilimsel makale" @default.
- Q37369917 description "scientific article published on 27 August 2009" @default.
- Q37369917 description "vedecký článok" @default.
- Q37369917 description "vetenskaplig artikel" @default.
- Q37369917 description "videnskabelig artikel" @default.
- Q37369917 description "vědecký článek" @default.
- Q37369917 description "wetenschappelijk artikel" @default.
- Q37369917 description "wissenschaftlicher Artikel" @default.
- Q37369917 description "наукова стаття, опублікована в серпні 2009" @default.
- Q37369917 description "научни чланак" @default.
- Q37369917 description "مقالة علمية نشرت في 27 أغسطس 2009" @default.
- Q37369917 name "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 name "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 name "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 type Item @default.
- Q37369917 label "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 label "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 label "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 prefLabel "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 prefLabel "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 prefLabel "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript." @default.
- Q37369917 P1433 Q37369917-1FCC075B-CB23-4051-A680-B037F697356A @default.
- Q37369917 P1476 Q37369917-031EAF33-4872-45B5-9BC5-305B9DC5DF32 @default.
- Q37369917 P2093 Q37369917-4A3A491F-1091-4E95-A2C7-85DF29BBBAA2 @default.
- Q37369917 P2093 Q37369917-6A019273-908B-462C-995A-0D8F53B5BECA @default.
- Q37369917 P2093 Q37369917-74047E1E-E7CB-4FED-8B8C-07BEF67B9CAC @default.
- Q37369917 P2093 Q37369917-868FF992-5A54-4E36-BCA7-C9392CE7AF46 @default.
- Q37369917 P2093 Q37369917-C6752D5D-01C9-4439-BCE2-EAC979B86C30 @default.
- Q37369917 P2093 Q37369917-FC0D93C7-DB69-45AD-9463-78796E88E460 @default.
- Q37369917 P2860 Q37369917-0FD9E76D-BE44-4460-AD16-A1B2E05FE50E @default.
- Q37369917 P2860 Q37369917-10F26E11-A6C1-4CC1-BECA-F622FBB3C4C5 @default.
- Q37369917 P2860 Q37369917-12D50B3B-3D38-4C66-835B-3274D896FF6A @default.
- Q37369917 P2860 Q37369917-18B1B01F-2972-4745-9BEF-DDF0CC432E46 @default.
- Q37369917 P2860 Q37369917-21B9DB25-02DD-4C54-BC43-66A824F7F42E @default.
- Q37369917 P2860 Q37369917-25D580D3-0CE2-45CF-A301-C45A141D4160 @default.
- Q37369917 P2860 Q37369917-32D8A528-672E-4223-B95A-E0616A80493F @default.
- Q37369917 P2860 Q37369917-41A7B559-A1FF-4CF6-8EB9-2037CADFA8F2 @default.
- Q37369917 P2860 Q37369917-470AA582-04AE-406D-B843-A0138ED2E0C5 @default.
- Q37369917 P2860 Q37369917-4918FF1B-19EC-41C3-99A2-C9239299D1EC @default.
- Q37369917 P2860 Q37369917-6D14400C-2527-4313-BA52-5A40D972EE8D @default.
- Q37369917 P2860 Q37369917-7CA6D592-CA47-4BB2-BF4E-57A90ED66828 @default.
- Q37369917 P2860 Q37369917-8637995C-220E-4EAF-9EAD-790E6C68E267 @default.
- Q37369917 P2860 Q37369917-B3D88714-2D81-4D9F-95FC-3DCDA89BBBBD @default.
- Q37369917 P2860 Q37369917-CF251D48-6554-4D46-AE4F-A49D72A2DB5F @default.
- Q37369917 P2860 Q37369917-CF597130-AE07-4FE2-B24D-DD435ED30BA4 @default.
- Q37369917 P2860 Q37369917-D09B4046-F1DA-44A6-8EAB-F6B308215561 @default.
- Q37369917 P2860 Q37369917-EB4C332C-0B4D-41A4-BAD1-CAC32F50143C @default.
- Q37369917 P2860 Q37369917-EF173668-7769-45DE-87EA-B5ECED36AE39 @default.
- Q37369917 P2860 Q37369917-F53386FE-CE2D-44C4-A496-9052F607D55F @default.
- Q37369917 P2860 Q37369917-FA3B486B-A538-4D17-8708-2DA3ADEA2D8D @default.
- Q37369917 P2860 Q37369917-FCACF18B-025E-4AC7-A768-812393482FC5 @default.
- Q37369917 P2860 Q37369917-FF1A93AE-F0B7-4C09-8DC1-904CB82BC41C @default.
- Q37369917 P304 Q37369917-C606EA40-AF66-498E-99B7-6EAB0310D87E @default.
- Q37369917 P31 Q37369917-92797756-AA99-4C9B-BC1F-8D23CCF84DD0 @default.
- Q37369917 P356 Q37369917-FC5EF1AF-493E-4021-BD29-A008F4608F07 @default.
- Q37369917 P407 Q37369917-F696155F-E5C0-4D85-A439-0FBDD7C40A1E @default.
- Q37369917 P433 Q37369917-31CF3EF0-3B4D-4444-AB9D-EE916673E158 @default.
- Q37369917 P478 Q37369917-B4C10781-9C11-4407-BD7E-6D715838962B @default.
- Q37369917 P50 Q37369917-497BB439-7707-4E05-833A-7CC5EDB8EF59 @default.
- Q37369917 P50 Q37369917-DE432217-960B-4599-B1D6-603646B338C8 @default.
- Q37369917 P577 Q37369917-4950B0B6-4472-459F-A6FB-E78ACF8EC15D @default.
- Q37369917 P5875 Q37369917-FC3D70EF-4BF2-4295-A9F3-F5683B697F23 @default.
- Q37369917 P698 Q37369917-9D152230-285E-49B6-B8B3-02563EE707E5 @default.
- Q37369917 P921 Q37369917-10758F69-8F43-4E2F-9F1E-E5E31D7BAEE9 @default.
- Q37369917 P921 Q37369917-14B9A004-B065-40AB-A6AA-D68A1CDAECE2 @default.
- Q37369917 P921 Q37369917-42C369F0-C331-4B19-BAEE-3617ED7FD840 @default.
- Q37369917 P921 Q37369917-891DB845-664D-49AB-A1E8-D8EEF36E2779 @default.
- Q37369917 P932 Q37369917-22EC53A9-6FBD-4D3C-A126-8B71675954AA @default.
- Q37369917 P356 HAEMATOL.2009.009134 @default.
- Q37369917 P698 19713230 @default.
- Q37369917 P1433 Q5638209 @default.
- Q37369917 P1476 "Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript" @default.
- Q37369917 P2093 "Andrea Davies" @default.
- Q37369917 P2093 "Katy Knight" @default.
- Q37369917 P2093 "Lihui Wang" @default.
- Q37369917 P2093 "Richard E Clark" @default.
- Q37369917 P2093 "Robert J Harris" @default.
- Q37369917 P2093 "Sarah J Watmough" @default.
- Q37369917 P2860 Q30326997 @default.
- Q37369917 P2860 Q34079452 @default.
- Q37369917 P2860 Q34341750 @default.
- Q37369917 P2860 Q34567629 @default.
- Q37369917 P2860 Q34572996 @default.
- Q37369917 P2860 Q37266504 @default.
- Q37369917 P2860 Q40119960 @default.
- Q37369917 P2860 Q42153441 @default.
- Q37369917 P2860 Q43685190 @default.
- Q37369917 P2860 Q43900370 @default.
- Q37369917 P2860 Q44054068 @default.
- Q37369917 P2860 Q44103818 @default.
- Q37369917 P2860 Q44727765 @default.
- Q37369917 P2860 Q46219786 @default.
- Q37369917 P2860 Q46406540 @default.
- Q37369917 P2860 Q46547149 @default.
- Q37369917 P2860 Q46562507 @default.